Hsbc Holdings PLC Buys 12,153 Shares of The Cooper Companies, Inc. $COO

Key Points

• Hsbc Holdings PLC increased its ownership in The Cooper Companies, Inc. by 3.1%, now holding approximately $34.35 million worth of shares.
• Recent analyst reports have resulted in a range of price target adjustments, with Wells Fargo lowering its target from $118.00 to $93.00 while Needham & Company raised it from "hold" to "buy" at $94.00.
• The Cooper Companies reported a quarterly earnings surprise, posting an EPS of $0.96, exceeding analysts' expectations, and projecting a yearly EPS guidance of 4.050-4.110 for FY 2025.

Hsbc Holdings PLC lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 407,793 shares of the medical device company's stock after purchasing an additional 12,153 shares during the quarter. Hsbc Holdings PLC owned about 0.20% of Cooper Companies worth $34,354,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Raymond James Financial Inc. boosted its stake in Cooper Companies by 2.1% during the 1st quarter. Raymond James Financial Inc. now owns 719,725 shares of the medical device company's stock valued at $60,709,000 after purchasing an additional 14,561 shares during the period. American Century Companies Inc. raised its holdings in shares of Cooper Companies by 0.9% during the first quarter. American Century Companies Inc. now owns 45,616 shares of the medical device company's stock valued at $3,848,000 after buying an additional 406 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Cooper Companies by 3.5% during the first quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company's stock worth $550,000 after buying an additional 220 shares during the period. Dimensional Fund Advisors LP increased its position in Cooper Companies by 4.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,621,839 shares of the medical device company's stock valued at $136,793,000 after acquiring an additional 63,681 shares during the period. Finally, Horizon Investments LLC raised its stake in Cooper Companies by 5.0% during the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock valued at $241,000 after acquiring an additional 136 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of research analyst reports. Loop Capital set a $100.00 price target on Cooper Companies in a report on Tuesday, June 17th. Piper Sandler reaffirmed an "overweight" rating and issued a $105.00 price target (down from $115.00) on shares of Cooper Companies in a research note on Friday, May 30th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $76.00 price objective (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Mizuho dropped their target price on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Finally, Wall Street Zen lowered Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $96.73.

Cooper Companies Trading Up 0.2%

COO stock traded up $0.18 during mid-day trading on Tuesday, reaching $73.66. 4,307,279 shares of the stock traded hands, compared to its average volume of 2,166,872. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38. The stock's fifty day moving average is $72.25 and its 200-day moving average is $77.94. The company has a market cap of $14.73 billion, a P/E ratio of 35.76, a P/E/G ratio of 1.83 and a beta of 1.00. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same quarter in the previous year, the business earned $0.85 earnings per share. The firm's revenue was up 6.3% compared to the same quarter last year. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.